Correspondence 0001213900-23-049254 from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: June 15, 2023 · CIK: 0001711786 · Accession: 0001213900-23-049254
AI Filing Summary & Sentiment
File numbers found in text: 333-272620
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics,
Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
June 15, 2023
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller
Re:
Hoth Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-272620
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:00 p.m., Eastern Standard Time, on Friday, June 16, 2023, or as soon thereafter as possible.
Please notify Nazia Khan of
Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer